How the Gut Microbiome Affects Overall Health: Diet, Brain, and Immunity

38 Trillion Microorganisms Share Your Body

A 2016 study published in Cell by Ron Sender and colleagues at the Weizmann Institute of Science revised the long-held estimate of microbial populations in the human body. The updated figure: approximately 38 trillion bacteria reside in and on a typical adult, with the vast majority living in the large intestine. That number roughly equals the total number of human cells. The collective genome of these microorganisms—the microbiome—contains over 3 million genes, dwarfing the 20,000 genes in the human genome. This ecosystem does not simply occupy space. It actively participates in digestion, immune regulation, vitamin synthesis, and even brain function.

Composition and Diversity of the Gut Ecosystem

The gut microbiome is dominated by bacteria, but it also includes archaea, fungi, viruses (including bacteriophages), and protists. Two bacterial phyla account for roughly 90% of gut bacteria in healthy adults: Firmicutes and Bacteroidetes. The ratio between these two groups, along with overall species diversity, has become a focus of research linking the microbiome to health outcomes.

Higher microbial diversity is consistently associated with better health outcomes. Reduced diversity appears in conditions ranging from obesity to inflammatory bowel disease. But correlation does not equal causation—a point researchers emphasize repeatedly.

The Gut-Brain Axis: A Two-Way Communication Network

The gut and the brain communicate through multiple pathways. The vagus nerve, the longest cranial nerve, provides a direct physical connection between the enteric nervous system (the gut's own neural network of over 500 million neurons) and the central nervous system. Gut bacteria also produce neurotransmitters. Approximately 95% of the body's serotonin is manufactured in the gut, not the brain.

Research findings on gut-brain communication:

• Germ-free mice (raised without any microbiome) show altered stress responses and anxiety-like behavior that normalizes when specific bacteria are introduced
• A 2019 study in Nature Microbiology analyzed data from over 1,000 participants in the Flemish Gut Flora Project and found that people with depression had consistently lower levels of Coprococcus and Dialister bacteria
• Probiotic supplementation with specific Lactobacillus and Bifidobacterium strains reduced self-reported symptoms of anxiety and depression in several randomized controlled trials, though effect sizes were modest
• The gut microbiome influences the hypothalamic-pituitary-adrenal (HPA) axis, the body's central stress response system

These findings have generated significant interest but also hype. Translating mouse studies to humans remains a major challenge. Clinical applications are still early-stage.

Immune System Training Starts in the Gut

Approximately 70% of the body's immune cells reside in the gut-associated lymphoid tissue (GALT). The microbiome plays a direct role in training these immune cells to distinguish between harmful pathogens and harmless substances, including food proteins and the body's own tissue.

Short-chain fatty acids (SCFAs)—butyrate, propionate, and acetate—are produced when gut bacteria ferment dietary fiber. Butyrate, in particular, feeds the cells lining the colon, strengthens the intestinal barrier, and has anti-inflammatory properties. When SCFA production drops due to low fiber intake or antibiotic use, the intestinal barrier can weaken, allowing bacterial components to enter the bloodstream and trigger systemic inflammation.

• Early childhood microbiome colonization influences lifelong immune development
• Children born by cesarean section have different initial microbiome compositions than those born vaginally
• Antibiotic use in the first year of life is associated with increased rates of allergies and asthma in epidemiological studies
• The "hygiene hypothesis" proposes that reduced microbial exposure in modern environments contributes to rising autoimmune and allergic disease rates

Diet Is the Strongest Modifiable Factor

Diet shapes the gut microbiome more powerfully than genetics, geography, or medications. A 2014 study by David and colleagues in Nature showed that switching between plant-based and animal-based diets altered the gut microbiome composition within 24 hours.

A 2021 Stanford study published in Cell by Wastyk and colleagues found that participants who ate six or more servings of fermented foods daily for 10 weeks showed increased microbiome diversity and reduced markers of inflammation, including interleukin-6. The high-fiber group, by contrast, did not show increased diversity over the same period—though their SCFA production increased.

Probiotics: Promise and Limitations

The global probiotics market reached $63 billion in 2023, but the science behind commercial probiotic products is more nuanced than marketing suggests. Probiotics are defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host.

What the evidence supports:

• Specific strains reduce the duration of acute infectious diarrhea by approximately one day
• Saccharomyces boulardii and Lactobacillus rhamnosus GG reduce antibiotic-associated diarrhea risk
• Certain multi-strain formulations show modest benefit in irritable bowel syndrome symptom management
• VSL#3 has shown efficacy in maintaining remission in ulcerative colitis in clinical trials

What the evidence does not support: the idea that any generic probiotic supplement meaningfully improves health in already healthy people. Strain specificity matters. Dose matters. Most commercial products do not match the strains or doses used in clinical research. A 2018 study in Cell by Zmora and colleagues even found that probiotic colonization varied dramatically between individuals—some people's guts resisted the introduced bacteria entirely.

The Microbiome's Role Is Still Being Written

The Human Microbiome Project, funded by the NIH from 2007 to 2016, cataloged the microbial communities across 300 healthy adults. That baseline data has fueled over a decade of research connecting the microbiome to conditions including obesity, diabetes, colorectal cancer, Parkinson's disease, and autism spectrum disorder. Fecal microbiota transplantation (FMT)—transferring stool from a healthy donor to a patient—has proven highly effective for recurrent Clostridioides difficile infection, with cure rates exceeding 90%.

Beyond C. diff, FMT and targeted microbiome therapies remain experimental. The complexity of the ecosystem—thousands of species interacting with each other, with the host's immune system, and with dietary inputs—makes simple interventions unlikely to produce universal benefits. The field is progressing, but slowly and carefully, from correlation toward causation.

This article is for informational purposes only. Consult a qualified professional.